Corvex (NASDAQ:MOVE) Stock Rating Upgraded by Chardan Capital

Corvex (NASDAQ:MOVEGet Free Report) was upgraded by Chardan Capital to a “strong-buy” rating in a research note issued to investors on Wednesday, Zacks reports.

Several other equities research analysts have also weighed in on the company. Wall Street Zen raised Corvex from a “sell” rating to a “hold” rating in a research report on Sunday, May 24th. Weiss Ratings upgraded shares of Corvex from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, September 3rd. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $18.75.

Read Our Latest Report on MOVE

Corvex Price Performance

Corvex stock opened at $10.92 on Wednesday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 4.28. The company has a fifty day simple moving average of $12.20 and a 200-day simple moving average of $15.32. The stock has a market cap of $344.53 million, a P/E ratio of -0.58 and a beta of 0.90. Corvex has a 12-month low of $3.44 and a 12-month high of $26.72.

Corvex (NASDAQ:MOVEGet Free Report) last posted its quarterly earnings results on Friday, August 14th. The AI infrastructure company reported ($5.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.17) by ($1.95). The business had revenue of $3.80 million during the quarter, compared to the consensus estimate of $6.71 million.

About Corvex

(Get Free Report)

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Featured Stories

Receive News & Ratings for Corvex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvex and related companies with MarketBeat.com's FREE daily email newsletter.